Skip to main content
PATH
NYSE Technology

UiPath Beats Q1 Revenue Estimates, Raises Full-Year Guidance, Achieves Q1 GAAP Profitability

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Software Stocks · Technology
Sentiment info
Positive
Importance info
8
Price
$11.7
Mkt Cap
$6.027B
52W Low
$9.2
52W High
$19.84
52W Position info
27% above low
Off High info
41% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

PATH sits 27% above its 52-week low of $9.2 on elevated volume (2.3× avg).

Summary

UiPath reported strong first-quarter results, beating revenue estimates and achieving Q1 GAAP profitability, while also raising its full-year revenue guidance.


Key Events · Earnings and Guidance · PATH

  • Strong Q1 Fiscal 2027 Results

    UiPath reported Q1 revenue of $418 million, a 17% year-over-year increase, significantly exceeding analyst estimates of $397.8 million. The company also achieved GAAP operating income of $28 million, marking its first fiscal first quarter of GAAP profitability.

  • Raised Full-Year Fiscal 2027 Guidance

    The company increased its full-year fiscal 2027 revenue outlook to a range of $1.776 billion to $1.781 billion, an upward revision from previous projections, signaling continued positive momentum.

  • CEO Adopts 10b5-1 Trading Plan

    CEO Daniel Dines adopted a pre-planned Rule 10b5-1 trading plan on April 15, 2026, to sell up to 2,975,000 shares through October 14, 2026. This plan is for personal tax, asset diversification, and liquidity, representing less than 5% of his total holdings.


Analysis · PATH · Technology

UiPath reported strong first-quarter results, significantly exceeding revenue estimates and achieving GAAP profitability for the first time in a fiscal first quarter. This positive performance is further reinforced by an upward revision of the full-year revenue guidance, indicating strong business momentum. While the CEO has adopted a pre-planned trading plan to sell a portion of his shares, this is a routine diversification move and represents a small percentage of his overall holdings, unlikely to overshadow the positive financial news.

How filings like this one have moved

In the 30 days to Sep 13, 2026, 35.4% of the 1304 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PATH was trading at $11.70 on NYSE in the Technology sector, with a market capitalization of approximately $6B. The 52-week trading range was $9.20 to $19.84. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PATH - Latest Insights

PATH
Sep 08, 2026, 5:22 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $13.98
Real-time Price: $13.76 info
Change: -$0.220 (-2%) info
Market Cap: $7.166B info
PATH
Sep 04, 2026, 12:33 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $15.22
Real-time Price: $13.76 info
Change: -$1.46 (-10%) info
Market Cap: $7.166B info
PATH
Sep 04, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $16.81
Real-time Price: $13.76 info
Change: -$3.05 (-18%) info
Market Cap: $7.166B info
PATH
Sep 03, 2026, 4:23 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.99
Real-time Price: $13.76 info
Change: -$5.23 (-28%) info
Market Cap: $7.166B info
PATH
Sep 03, 2026, 4:10 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $18.75
Real-time Price: $13.76 info
Change: -$4.99 (-27%) info
Market Cap: $7.166B info